Expert Outlook: Viridian Therapeutics Through The Eyes Of 10 Analysts
Expert Outlook: Viridian Therapeutics Through The Eyes Of 10 Analysts
專家展望：通過10位分析師的視角看Viridian Therapeutics
An in...Across the recent three months, 10 analysts have shared their insights on Viridian Therapeutics (NASDAQ:VRDN), expressing a variety of opinions spanning from bullish to bearish.
在最近的三個月裏，10位分析師分享了他們對維裏迪安治療公司（納斯達克:VRDN）的見解，表達了從看好到看淡的各種意見。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下面的表格中，您將找到他們最近評級的摘要，揭示了過去30天情緒的變化，並與前幾個月進行了比較。
Analysts have set 12-month price targets for Viridian Therapeutics, revealing an average target of $37.2, a high estimate of $47.00, and a low estimate of $27.00. Observing a downward trend, the current average is 0.05% lower than the prior average price target of $37.22.
分析師爲Viridian Therapeutics設定了12個月的價格目標，平均目標爲37.2美元，最高估計爲47.00美元，最低估計爲27.00美元。觀察到下行趨勢，當前平均值比之前的平均價格目標37.22美元低0.05%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
An in...
對近...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間